| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated dissemination of non small cell carcinoma after curative resection
|
Rathinam, S.
|
|
2009
|
63 |
S1 |
p. S36-
1 p.
|
artikel
|
| 2 |
Accuracy of lung tumour measurements on staging MDCT compared to the final pathological tumour size
|
Raj, J.V.
|
|
2009
|
63 |
S1 |
p. S18-S19
2 p.
|
artikel
|
| 3 |
A clinical audit on the use of palliative carboplatin/vinorelbine chemotherapy in non small cell lung cancer
|
Wood, J.P.
|
|
2009
|
63 |
S1 |
p. S4-
1 p.
|
artikel
|
| 4 |
A comparison of a new endobronchial ultrasound service with an established endoscopic ultrasound service for mediastinal lymph node sampling
|
Woolhouse, I.
|
|
2009
|
63 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 5 |
Adjuvant chemotherapy of resected NSCLC with 4 cycles of 3-weekly cisplatin 80 mg/m2 plus gemcitabine 1250 mg/m2. High dose intensity and good tolerance
|
Ahmed, A.
|
|
2009
|
63 |
S1 |
p. S7-S8
2 p.
|
artikel
|
| 6 |
An analysis of rate of admissions to an inpatient facility across 3 trusts in relation to the delivery of docetaxel chemotherapy in non small cell lung cancer (NSCLC)
|
Sharma, A.
|
|
2009
|
63 |
S1 |
p. S6-
1 p.
|
artikel
|
| 7 |
An audit of neutropaenia in patients with small cell lung carcinoma (SCLC) undergoing platinum-based chemotherapy – urgent need for specific SCLC guidelines
|
Benning, J.
|
|
2009
|
63 |
S1 |
p. S13-
1 p.
|
artikel
|
| 8 |
An audit of PCI in SCLC – Kent Oncology Centre
|
Verma, A.
|
|
2009
|
63 |
S1 |
p. S13-
1 p.
|
artikel
|
| 9 |
An audit of SCLC patients not receiving chemotherapy
|
Morris, J.
|
|
2009
|
63 |
S1 |
p. S10-
1 p.
|
artikel
|
| 10 |
An audit of two first line platinum doublets in advanced NSCLC
|
El-Modir, A.
|
|
2009
|
63 |
S1 |
p. S9-
1 p.
|
artikel
|
| 11 |
An interim report of the Chemotherapy In Mesothelioma Project (ChIMP)
|
Darlison, A.E.
|
|
2009
|
63 |
S1 |
p. S29-
1 p.
|
artikel
|
| 12 |
A Northern Cancer Network (NCN) retrospective study of outcomes for small cell lung cancer (SCLC)
|
Jones, C.
|
|
2009
|
63 |
S1 |
p. S11-
1 p.
|
artikel
|
| 13 |
A nurse led assessment clinic for patients suspected of having lung cancer: improving the patients' experience
|
Irvine, L.
|
|
2009
|
63 |
S1 |
p. S32-
1 p.
|
artikel
|
| 14 |
Are patients being appropriately referred for the investigation of suspected lung cancer
|
Sharp, T.
|
|
2009
|
63 |
S1 |
p. S17-
1 p.
|
artikel
|
| 15 |
A review of key roles of Scottish lung cancer nurses
|
Borthwick, D.
|
|
2009
|
63 |
S1 |
p. S33-
1 p.
|
artikel
|
| 16 |
A study to find a suitable fiducial marker to validate the use of non-rigid registration (NRR) algorithms and 4D-CT motion modelling in lung cancer radiotherapy
|
Hughes, S.
|
|
2009
|
63 |
S1 |
p. S34-
1 p.
|
artikel
|
| 17 |
Audit of epidermal growth factor receptor (EGFR) expression by immunohistochemistry (IHC) using Dako and Ventana clones in non-small cell lung cancer (NSCLC)
|
Baird, R.
|
|
2009
|
63 |
S1 |
p. S2-S3
2 p.
|
artikel
|
| 18 |
Audit of patients in NHS Highland documented as refusing treatment in 2007
|
Morrison, L.
|
|
2009
|
63 |
S1 |
p. S14-
1 p.
|
artikel
|
| 19 |
Audit of telephone follow-up for patients receiving radical radiotherapy for lung cancer
|
Dawson, F.
|
|
2009
|
63 |
S1 |
p. S31-
1 p.
|
artikel
|
| 20 |
Audit of treatment decision making in patients with new diagnosis of lung cancer
|
Ismail, I.M.
|
|
2009
|
63 |
S1 |
p. S15-
1 p.
|
artikel
|
| 21 |
Author index
|
|
|
2009
|
63 |
S1 |
p. S39-S42
4 p.
|
artikel
|
| 22 |
A 5-year audit of lung surgery for bronchial carcinoma in the elderly
|
Talla, M.R.
|
|
2009
|
63 |
S1 |
p. S37-S38
2 p.
|
artikel
|
| 23 |
Brain metastases in patients with extensive stage small cell lung cancer who had a response to chemotherapy a single centre experience
|
Botten, J.
|
|
2009
|
63 |
S1 |
p. S12-
1 p.
|
artikel
|
| 24 |
Case report of squamous cell carcinoma of the lung T2 N0 and M1 with good response to treatment, underwent left upper lobectomy, presenting with intramedullary spinal cord lesion
|
Khan, M.H.
|
|
2009
|
63 |
S1 |
p. S14-
1 p.
|
artikel
|
| 25 |
Chemotherapy for malignant pleural mesothelioma a single institution experience
|
Arif, S.S.
|
|
2009
|
63 |
S1 |
p. S27-
1 p.
|
artikel
|
| 26 |
Chemotherapy for malignant pleural mesothelioma (MPM) in the era of pemetrexed: experience in Northern Ireland
|
Campbell, L.
|
|
2009
|
63 |
S1 |
p. S8-
1 p.
|
artikel
|
| 27 |
Chemotherapy for NSCLC: comparison between cisplatin/docetaxel and other combinations – a Northwest England experience
|
Mehta, A.
|
|
2009
|
63 |
S1 |
p. S7-
1 p.
|
artikel
|
| 28 |
Chronic obstructive pulmonary disease in lung cancer – underdiagnosed and undertreated
|
Myerson, J.S.
|
|
2009
|
63 |
S1 |
p. S24-
1 p.
|
artikel
|
| 29 |
Comparing hospital contact between different treatment pathways in mesothelioma
|
Darlison, A.E.
|
|
2009
|
63 |
S1 |
p. S29-
1 p.
|
artikel
|
| 30 |
Comparison of diagnostic sensitivity for thoracic malignancy with and without endobronchial ultrasound
|
Tobin, C.
|
|
2009
|
63 |
S1 |
p. S22-S23
2 p.
|
artikel
|
| 31 |
Consultant led, consultant delivered, customer friendly a patients' perspective of the acute interventional airway service provided at South Manchester
|
Rammohan, K.S.
|
|
2009
|
63 |
S1 |
p. S37-
1 p.
|
artikel
|
| 32 |
CONVERT: Concurrent once-daily versus twice-daily radiotherapy – a new phase III randomised controlled trial for patients with limited-stage small cell lung cancer and good performance status
|
Faivre-Finn, C.
|
|
2009
|
63 |
S1 |
p. S12-
1 p.
|
artikel
|
| 33 |
Correlation of pre-operative radiological staging (CT and PET/CT) with pathological staging in patients with resectable non-small cell lung cancer (NSCLC) attending a regional thoracic centre – a real world perspective!
|
Jafri, M.
|
|
2009
|
63 |
S1 |
p. S20-
1 p.
|
artikel
|
| 34 |
CT guided lung biopsy: a comparison of specialist registrar versus consultant performed biopsies
|
Entwisle, J.J.
|
|
2009
|
63 |
S1 |
p. S23-
1 p.
|
artikel
|
| 35 |
30-day death rates in lung cancer patients treated with chemotherapy in SE Wales
|
Lester, J.F.
|
|
2009
|
63 |
S1 |
p. S5-
1 p.
|
artikel
|
| 36 |
Detection of brain metastases in patients having had surgery for NSCLC – an outcome audit
|
Moholkar, S.
|
|
2009
|
63 |
S1 |
p. S19-
1 p.
|
artikel
|
| 37 |
Detection of EGFR and KRAS mutations in circulating free DNA in patients with operable non small cell lung cancer (NSCLC)
|
Board, R.
|
|
2009
|
63 |
S1 |
p. S20-
1 p.
|
artikel
|
| 38 |
Developing a guideline to enable lung cancer nurse specialists to consistently communicate key MDT decisions to patients
|
Bolton, S.
|
|
2009
|
63 |
S1 |
p. S32-
1 p.
|
artikel
|
| 39 |
Early lung cancer intervention in Doncaster (ElCiD)
|
Tod, A.M.
|
|
2009
|
63 |
S1 |
p. S19-
1 p.
|
artikel
|
| 40 |
EBUS-TBNA for staging of lung cancer – initial Irish experience
|
Lyons, O.
|
|
2009
|
63 |
S1 |
p. S19-
1 p.
|
artikel
|
| 41 |
Endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with non-small cell lung cancer: systematic review and meta-analysis
|
Adams, K.
|
|
2009
|
63 |
S1 |
p. S21-S22
2 p.
|
artikel
|
| 42 |
Epigenetic regulation of prostacyclin synthase (PTGIS) in non-small cell lung cancer (NSCLC)
|
Cathcart, M.C.
|
|
2009
|
63 |
S1 |
p. S2-
1 p.
|
artikel
|
| 43 |
Erlotinib and docetaxel in relapsed non-small cell lung cancer: a single centre experience
|
Hook, J.
|
|
2009
|
63 |
S1 |
p. S8-
1 p.
|
artikel
|
| 44 |
Erlotinib use in NSCLC – the Lanarkshire experience
|
MacLeod, N.
|
|
2009
|
63 |
S1 |
p. S4-
1 p.
|
artikel
|
| 45 |
Establishing a national mesothelioma nurses action team (M-NAT)
|
Darlison, A.E.
|
|
2009
|
63 |
S1 |
p. S33-S34
2 p.
|
artikel
|
| 46 |
Evaluating the roles of TNF, IL-1 and hypoxia in lung carcinogenesis
|
Baird, A.M.
|
|
2009
|
63 |
S1 |
p. S1-S2
2 p.
|
artikel
|
| 47 |
Evaluation of oral vinorelbine for the management of non-small cell lung cancer
|
Ward, C.
|
|
2009
|
63 |
S1 |
p. S9-
1 p.
|
artikel
|
| 48 |
Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis
|
Razak, A.R. Abdul
|
|
2009
|
63 |
S1 |
p. S27-
1 p.
|
artikel
|
| 49 |
Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited-stage small cell lung cancer (LS-SCLC)
|
Sheikh, H.
|
|
2009
|
63 |
S1 |
p. S11-S12
2 p.
|
artikel
|
| 50 |
18F-FDG PET-CT based target volume definition in non-small cell lung cancer reduces inter-observer variation in already PET-CT staged patients
|
Hanna, G.G.
|
|
2009
|
63 |
S1 |
p. S34-S35
2 p.
|
artikel
|
| 51 |
French window thoracotomy: a case-control study of lung resection via a novel non-rib spreading thoracotomy
|
Vaughan, P.
|
|
2009
|
63 |
S1 |
p. S35-
1 p.
|
artikel
|
| 52 |
From suspiciously malignant to benign: a pictorial review of FDG PET negative pulmonary lesions on PET/CT and conventional computed tomography
|
Nathan, M.
|
|
2009
|
63 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 53 |
Impact of introduction of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) upon a lung cancer diagnostic service
|
Patel, M.
|
|
2009
|
63 |
S1 |
p. S18-
1 p.
|
artikel
|
| 54 |
Impact of positive pleural lavage cytology on survival in patients undergoing lung resection for NSCLC
|
Lim, E.
|
|
2009
|
63 |
S1 |
p. S17-
1 p.
|
artikel
|
| 55 |
Implementing palliative care for lung cancer patients in a newly established cardiothoracic centre
|
Devenay, S.
|
|
2009
|
63 |
S1 |
p. S32-S33
2 p.
|
artikel
|
| 56 |
Improving the patient experience of the lung cancer pathway in the emergency assessment unit
|
Fitzpatrick, T.
|
|
2009
|
63 |
S1 |
p. S33-
1 p.
|
artikel
|
| 57 |
Increased incidence of post-operative acute lung injury after neoadjuvent chemotherapy for lung cancer: is a drug-induced pneumonitis the culprit?
|
Hendron, D.
|
|
2009
|
63 |
S1 |
p. S35-S36
2 p.
|
artikel
|
| 58 |
Increasing the pre-test probability of cancer improves the diagnostic accuracy of transbronchial needle aspiration (TBNA)
|
Verma, R.
|
|
2009
|
63 |
S1 |
p. S17-
1 p.
|
artikel
|
| 59 |
Investigation of thromboxane synthase expression profile as a potential survival factor in NSCLC
|
Cathcart, M.C.
|
|
2009
|
63 |
S1 |
p. S2-
1 p.
|
artikel
|
| 60 |
Kent chemotherapy partnership: sharing ideas, improving outcomes
|
Maynard, C.
|
|
2009
|
63 |
S1 |
p. S5-S6
2 p.
|
artikel
|
| 61 |
LASER in airway palliation: a single centre experience
|
Rathinam, S.
|
|
2009
|
63 |
S1 |
p. S36-S37
2 p.
|
artikel
|
| 62 |
Leeds LCNS mesothelioma audit 2004–8
|
White, J.
|
|
2009
|
63 |
S1 |
p. S33-
1 p.
|
artikel
|
| 63 |
Life after first line chemotherapy in malignant pleural mesothelioma
|
Bough, G.
|
|
2009
|
63 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 64 |
Long term exposure to tyrosine kinase inhibitors (TKI): case report and review
|
Quintyne, K.I.
|
|
2009
|
63 |
S1 |
p. S3-
1 p.
|
artikel
|
| 65 |
Lung cancer survival in Leicestershire: 1992–2006
|
Ohri, C.M.
|
|
2009
|
63 |
S1 |
p. S30-
1 p.
|
artikel
|
| 66 |
Lymph node lessons: a retrospective audit of station sampling
|
Messer, S.
|
|
2009
|
63 |
S1 |
p. S36-
1 p.
|
artikel
|
| 67 |
MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) as adjuvant therapy in resected stage IB/II non-small cell lung cancer (NSCLC): from proof-of-concept to phase III trial (MAGRIT)
|
Eisen, T.
|
|
2009
|
63 |
S1 |
p. S10-
1 p.
|
artikel
|
| 68 |
Malnutrition in lung cancer (MILC). A pilot audit of psychosocial and biophysical markers of malnutrition
|
Brisbane, I.
|
|
2009
|
63 |
S1 |
p. S16-
1 p.
|
artikel
|
| 69 |
Mesothelioma and radical surgery trial (MARS): the feasibility study process
|
Treasure, T.
|
|
2009
|
63 |
S1 |
p. S26-
1 p.
|
artikel
|
| 70 |
Mesothelioma multi-disciplinary team meeting (MDT) – how often does specialist pathological review change the diagnosis?
|
Lester, J.F.
|
|
2009
|
63 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 71 |
Metabolic targeting, HDAC inhibitors, and non small cell lung cancer?
|
Gray, S.G.
|
|
2009
|
63 |
S1 |
p. S1-
1 p.
|
artikel
|
| 72 |
Oncolytic virus therapy for mesothelioma – a phase I trial proposal
|
Woll, P.J.
|
|
2009
|
63 |
S1 |
p. S26-S27
2 p.
|
artikel
|
| 73 |
Outcome for patients with small cell lung cancer (SCLC) in Mid-Western Ireland
|
Quintyne, K.I.
|
|
2009
|
63 |
S1 |
p. S10-S11
2 p.
|
artikel
|
| 74 |
Pacemaker induced malignant inflammatory myofibroblastic tumour
|
Rathinam, S.
|
|
2009
|
63 |
S1 |
p. S37-
1 p.
|
artikel
|
| 75 |
Palliative chemotherapy for non-small cell lung cancer (NSCLC) patients with performance status (PS) 2: results of an online survey of British Thoracic Oncology Group (BTOG) members
|
Jones, C.
|
|
2009
|
63 |
S1 |
p. S6-
1 p.
|
artikel
|
| 76 |
“Part of life's great tapestry” – patients' experiences of interval computerised tomography (CT) scanning to evaluate and monitor solitary pulmonary nodules (SPNs)
|
Downer, P.
|
|
2009
|
63 |
S1 |
p. S25-
1 p.
|
artikel
|
| 77 |
PET-CT in non-small cell lung cancer – time for a more streamlined approach?
|
Kyi, M.M.
|
|
2009
|
63 |
S1 |
p. S22-
1 p.
|
artikel
|
| 78 |
PET-CT scanning for lung cancer: an audit of clinical practice and outcomes
|
Gillon, S.
|
|
2009
|
63 |
S1 |
p. S18-
1 p.
|
artikel
|
| 79 |
PIT. A phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention
|
Bayman, N.A.
|
|
2009
|
63 |
S1 |
p. S25-
1 p.
|
artikel
|
| 80 |
Pleural neurofibroma: description of the first two cases of a rare pleural tumour
|
Rathinam, S.
|
|
2009
|
63 |
S1 |
p. S16-
1 p.
|
artikel
|
| 81 |
Positron emission tomography and nodal staging in non-small cell lung cancer? The Birmingham experience
|
Woolley, S.
|
|
2009
|
63 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 82 |
Preventing unnecessary oncology outpatient appointments during the lung cancer patient pathway
|
Borgen, P.
|
|
2009
|
63 |
S1 |
p. S29-
1 p.
|
artikel
|
| 83 |
Prognostic factors in patients with small cell lung cancer (SCLC) in Mid-West Ireland
|
Quintyne, K.I.
|
|
2009
|
63 |
S1 |
p. S11-
1 p.
|
artikel
|
| 84 |
Prolonged investigation of operable NSCLC patients following PET scan increases the incidence of metastases and recurrence of disease
|
Booth, K.L.
|
|
2009
|
63 |
S1 |
p. S21-
1 p.
|
artikel
|
| 85 |
Prophylactic cranial irradiation (PCI) in extensive stage small cell lung cancer (ED-SCLC): a retrospective review of practice at the Northern Centre for Cancer Treatment
|
Graham, J.E.
|
|
2009
|
63 |
S1 |
p. S12-S13
2 p.
|
artikel
|
| 86 |
Quality of life after radiotherapy and steroids in patients with inoperable brain metastases from non-small cell lung cancer: the QUARTZ trial
|
Stephens, R.
|
|
2009
|
63 |
S1 |
p. S34-
1 p.
|
artikel
|
| 87 |
Radical radiotherapy for non small cell lung cancer
|
Biswas, D.
|
|
2009
|
63 |
S1 |
p. S35-
1 p.
|
artikel
|
| 88 |
Radiofrequency ablation for pulmonary neoplasms: initial results and patient pathway
|
Zacharkiw, A.
|
|
2009
|
63 |
S1 |
p. S30-S31
2 p.
|
artikel
|
| 89 |
Rapid access lung cancer referral service for general practitioners
|
Wignall, G.
|
|
2009
|
63 |
S1 |
p. S23-
1 p.
|
artikel
|
| 90 |
Referral guidelines for suspected lung cancer; are they useful and are they followed? An audit from the Pan-Birmingham Cancer Network
|
Choo, C.
|
|
2009
|
63 |
S1 |
p. S31-
1 p.
|
artikel
|
| 91 |
Reflecting on mesothelioma patients in Leicestershire 2004–2008
|
Darlison, A.E.
|
|
2009
|
63 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 92 |
Retrospective analysis of EDTA-GFR versus Cockcroft-Gault formula in lung patients receiving carboplatin chemotherapy
|
Lees, K.
|
|
2009
|
63 |
S1 |
p. S7-
1 p.
|
artikel
|
| 93 |
Safety and tolerability of single agent oral vinorelbine in elderly and poor performance status patients with non-small cell lung cancer
|
Bhattacharyya, M.
|
|
2009
|
63 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 94 |
Specialist care at a local unit: the Medway Maritime Hospital experience
|
Taylor, H.
|
|
2009
|
63 |
S1 |
p. S28-
1 p.
|
artikel
|
| 95 |
Starting an ambulatory pleural drainage service for malignant effusion
|
Slade, G.
|
|
2009
|
63 |
S1 |
p. S28-
1 p.
|
artikel
|
| 96 |
Surgical resection for thymic malignancy
|
Qureshi, S.
|
|
2009
|
63 |
S1 |
p. S38-
1 p.
|
artikel
|
| 97 |
Survey to identify complementary medicine and supplement use in lung cancer and mesothelioma patients in a district general hospital
|
Waite, K.
|
|
2009
|
63 |
S1 |
p. S15-S16
2 p.
|
artikel
|
| 98 |
Survival outcomes in WHO PS 2 patients and elderly patients with stage IIIB/IV non small cell lung cancer treated with carboplatin and gemcitabine
|
Gokul, S.
|
|
2009
|
63 |
S1 |
p. S7-
1 p.
|
artikel
|
| 99 |
The effects of metastasis supressor-1 gene on the migratory properties of non small cell lung cancer
|
Noble, S.I.R.
|
|
2009
|
63 |
S1 |
p. S3-
1 p.
|
artikel
|
| 100 |
The importance of ultrasound in the pathological diagnosis of lung cancer
|
Hoosein, M.M.
|
|
2009
|
63 |
S1 |
p. S21-
1 p.
|
artikel
|
| 101 |
The National Lung Cancer Audit Database (LUCADA); essential analysis of data quality
|
Rich, A.L.
|
|
2009
|
63 |
S1 |
p. S14-S15
2 p.
|
artikel
|
| 102 |
The oncology referral patterns and post operative adjuvant treatment of patients undergoing curative resections for non small cell lung cancer in a tertiary thoracic centre
|
Pai, R.K.
|
|
2009
|
63 |
S1 |
p. S30-
1 p.
|
artikel
|
| 103 |
The potential for tailored therapy based on molecular characteristics of endobronchial tumour sampling at diagnosis
|
Medley, L.
|
|
2009
|
63 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 104 |
The use of erlotinib in the management of non small cell lung cancer: North of England Cancer Network experience
|
Azribi, F.
|
|
2009
|
63 |
S1 |
p. S8-S9
2 p.
|
artikel
|
| 105 |
The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer (NSCLC) patients
|
Faria, A.
|
|
2009
|
63 |
S1 |
p. S4-
1 p.
|
artikel
|
| 106 |
The wide variation in response of mesothelioma cell lines to pemetrexed and lack of relationship to presence of folate receptor alpha (Fra).
|
Nutt, J.E.
|
|
2009
|
63 |
S1 |
p. S26-
1 p.
|
artikel
|
| 107 |
Thymomas presentations and up-to-date management, series of 14 cases and review of the literature
|
Fayaz, M.
|
|
2009
|
63 |
S1 |
p. S14-
1 p.
|
artikel
|
| 108 |
Tissue is t'issue: ‘hot’ nodes at PET-CT for non-small cell lung cancer need histology
|
Kyi, M.M.
|
|
2009
|
63 |
S1 |
p. S22-
1 p.
|
artikel
|
| 109 |
Treatment-associated deaths and mortality following chemotherapy for non-small cell lung cancer
|
Soffin, E.
|
|
2009
|
63 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 110 |
UK lung cancer attitude assessment project
|
Dunlop, J.
|
|
2009
|
63 |
S1 |
p. S15-
1 p.
|
artikel
|
| 111 |
Uptake and delivery of adjuvant chemotherapy in resected non-small cell lung cancer: experience in Northern Ireland Cancer Centre
|
Ahmad, A.R.
|
|
2009
|
63 |
S1 |
p. S9-
1 p.
|
artikel
|
| 112 |
Use of chemotherapy in advanced NSCLC – results from the National Lung Cancer Audit
|
Beckett, P.
|
|
2009
|
63 |
S1 |
p. S3-
1 p.
|
artikel
|
| 113 |
Use of erlotinib in patients selected using clinical criteria in the 2nd and 3rd line treatment of non-small cell lung cancer (NSCLC)
|
Stavridi, F.
|
|
2009
|
63 |
S1 |
p. S5-
1 p.
|
artikel
|
| 114 |
VEGF and the epigenetic regulation of its receptors in non-small cell lung cancer
|
Barr, M.
|
|
2009
|
63 |
S1 |
p. S1-
1 p.
|
artikel
|
| 115 |
What is the shelf life of PET-CT staging of the mediastinum in non-small cell lung cancer?
|
Hanna, G.G.
|
|
2009
|
63 |
S1 |
p. S24-
1 p.
|
artikel
|
Tijdschrift beschrijving